They have increased levels of angiotensin II, TGF-β signaling, adipose tissue, systemic inflammation Campo (160), larger atria, lower atrial voltage, and higher recurrence of AF after ablation (161). The gene discussed is TGFB1; the disease is atrial fibrillation.